注射用血栓通治疗急性脑梗死的临床疗效及安全性观察

目的观察分析血栓通用于治疗急性脑梗死的临床疗效及安全性。方法选择于2011年3月至2012年4月在我院接受治疗的100例急性脑梗死患者随机分为两组,对照组和观察组,每组各50例;对照组的患者采用常规的治疗的方法,观察组的患者在对照组患者治疗的基础上加用血栓通治疗,治疗14d后比较两组患者临床疗效、血小板和凝血常规以及临床神经功能缺损程度评分(NDS)进行综合评定。结果 14d后观察组临床疗效明显优于对照组(P<0.05),血小板和凝血指标等都在正常范围内,神经功能的缺损程度明显降低,且优于对照组(P<0.05)。结论血栓通用于治疗急性脑梗死疗效较好,且具有较高的可靠性和安全性。

The Injection Xueshuantong the Treatment of Acute Cerebral Infarction with Clinical Efficacy and Safety Observed

Objective Observation and analysis of Xueshuantong for the treatment of acute cerebral infarction clinical curative effect and safety.Methods Select 100 cases of acute cerebral infarction patients treated in our hospital from March 2011 to April 2012 were randomLy divided into two groups,Control group and observation group,50 cases in each group,The control group were treated with conventional treatment methods,Patients in the control group patients on the basis of the observation group plus Xueshuantong treatment,After 14 days of treatment were compared between the two groups of patients with clinical efficacy,platelets and coagulation in conventional as well as clinical neurological deficit scores（NDS）comprehensive evaluation.Results 14 days after the clinical efficacy of the observation group than the control group（P0.05）,Platelets and coagulation indicators are all within the normal range,Impairment of nerve function significantly reduced,And better than the control group（P0.05）.Conclusion Xueshuantong used for the treatment of acute cerebral infarction is better,And has high reliability and security.